Skip to main content
. 2022 Mar 2;57(4):246–266. doi: 10.1007/s00535-022-01862-y

Table 2.

Number and frequency of EIs in recent clinical trials for UC

Survey period Index Validation Number (%)
1999–2008 (N = 147, including duplicates)
Baron score Validated 68 (46.2%)
Rachmilewitz endoscopic index Not validated 35 (23.8%)
Matts score Not validated 6 (4.1%)
Tygat Endoscopic grading score Unknown 4 (2.7%)
Others (Including original indices for the trial) Not available 34 (23.1%)
2009–2012 (N = 58, including duplicates)
Mayo Score (Including Mayo Endoscopic Sub-score) Not validated 25 (42.4%)
DAI Score (Including Sutherland Index) Not validated 24 (40.7%)
Rachmilewitz endoscopic index Not validated 5 (8.5%)
Pouchitis Disease Activity Index (PDAI) Not validated 2 (3.4%)
Matts Classification Not validated 2 (3.4%)
Others (Including original indices for the trial) Not available 5 (8.5%)
2013–2017 (N = 126, including duplicates)
Mayo Score (Including Mayo Endoscopic Sub-score) Not validated 87 (69.0%)
DAI Score (Including Sutherland Index) Not validated 25 (19.8%)
Baron Score (Including modified Baron Score) Validated 7 (5.6%)
Pouchitis Disease Activity Index (PDAI) Not validated 6 (4.8%)
Rachmilewitz endoscopic index Not validated 6 (4.8%)
Ulcerative Colitis Endoscopic Index of Severity (UCEIS) Validated 6 (4.8%)
Matts Classification Not available 5 (4.0%)

DAI disease activity index, EIs endoscopic indices, UC ulcerative colitis